These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 17547686

  • 1. Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.
    Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):270-5. PubMed ID: 17547686
    [Abstract] [Full Text] [Related]

  • 2. Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART).
    Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR.
    Clin Endocrinol (Oxf); 2012 May; 76(5):643-8. PubMed ID: 22040002
    [Abstract] [Full Text] [Related]

  • 3. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.
    Clin Infect Dis; 2005 Dec 01; 41(11):1662-70. PubMed ID: 16267741
    [Abstract] [Full Text] [Related]

  • 4. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
    Delpierre C, Bonnet E, Marion-Latard F, Aquilina C, Obadia M, Marchou B, Massip P, Perret B, Bernard J.
    J Clin Densitom; 2007 Dec 01; 10(4):376-80. PubMed ID: 17888698
    [Abstract] [Full Text] [Related]

  • 5. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
    Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Mannazzu M, Falchi A, Sanna D, Mura MS, Madeddu G.
    Q J Nucl Med Mol Imaging; 2009 Jun 01; 53(3):290-301. PubMed ID: 18596668
    [Abstract] [Full Text] [Related]

  • 6. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB, Lindegaard B, Obel N, Andersen O, Nielsen H, Gerstoft J.
    HIV Med; 2006 Jan 01; 7(1):38-45. PubMed ID: 16313291
    [Abstract] [Full Text] [Related]

  • 7. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D, Dorgeret S, Lescoeur B, Alberti C, Noel M, Czernichow P, Sebag G, Vilmer E, Léger J.
    Pediatrics; 2005 Jul 01; 116(1):e102-8. PubMed ID: 15995009
    [Abstract] [Full Text] [Related]

  • 8. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
    Maia BS, Engelson ES, Wang J, Kotler DP.
    Clin Nutr; 2005 Dec 01; 24(6):971-8. PubMed ID: 16095765
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal changes in serum lipids among HIV-infected men on highly active antiretroviral therapy.
    Riddler SA, Li X, Chu H, Kingsley LA, Dobs A, Evans R, Palella F, Visscher B, Chmiel JS, Sharrett A.
    HIV Med; 2007 Jul 01; 8(5):280-7. PubMed ID: 17561873
    [Abstract] [Full Text] [Related]

  • 10. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
    Saghayam S, Kumarasamy N, Cecelia AJ, Solomon S, Mayer K, Wanke C.
    Clin Infect Dis; 2007 Jan 15; 44(2):295-300. PubMed ID: 17173234
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy.
    Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR.
    Clin Endocrinol (Oxf); 2006 Aug 15; 65(2):191-7. PubMed ID: 16886959
    [Abstract] [Full Text] [Related]

  • 12. BMD is reduced in HIV-infected men irrespective of treatment.
    Amiel C, Ostertag A, Slama L, Baudoin C, N'Guyen T, Lajeunie E, Neit-Ngeilh L, Rozenbaum W, De Vernejoul MC.
    J Bone Miner Res; 2004 Mar 15; 19(3):402-9. PubMed ID: 15040828
    [Abstract] [Full Text] [Related]

  • 13. Spinal bone mineral density in premenopausal vegetarian and nonvegetarian women: cross-sectional and prospective comparisons.
    Barr SI, Prior JC, Janelle KC, Lentle BC.
    J Am Diet Assoc; 1998 Jul 15; 98(7):760-5. PubMed ID: 9664916
    [Abstract] [Full Text] [Related]

  • 14. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
    Madeddu G, Spanu A, Solinas P, Calia GM, Lovigu C, Chessa F, Mannazzu M, Falchi A, Mura MS, Madeddu G.
    Q J Nucl Med Mol Imaging; 2004 Mar 15; 48(1):39-48. PubMed ID: 15195003
    [Abstract] [Full Text] [Related]

  • 15. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
    Schindler K, Rieger A, Tura A, Gmeinhardt B, Touzeau-Römer V, Haider D, Pacini G, Ludvik B.
    Horm Metab Res; 2009 Jul 15; 41(7):573-9. PubMed ID: 19322744
    [Abstract] [Full Text] [Related]

  • 16. Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma.
    Lee H, McGovern K, Finkelstein JS, Smith MR.
    Cancer; 2005 Oct 15; 104(8):1633-7. PubMed ID: 16116596
    [Abstract] [Full Text] [Related]

  • 17. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, Mercié P, Morlat P, Thiébaut R, Dabis F, Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    AIDS; 2008 Jan 30; 22(3):395-402. PubMed ID: 18195566
    [Abstract] [Full Text] [Related]

  • 18. Impact on weight and height with the use of HAART in HIV-infected children.
    Guillén S, Ramos JT, Resino R, Bellón JM, Muñoz MA.
    Pediatr Infect Dis J; 2007 Apr 30; 26(4):334-8. PubMed ID: 17414398
    [Abstract] [Full Text] [Related]

  • 19. Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment.
    Briot K, Gossec L, Kolta S, Dougados M, Roux C.
    J Rheumatol; 2008 May 30; 35(5):855-61. PubMed ID: 18381782
    [Abstract] [Full Text] [Related]

  • 20. Body habitus changes, metabolic abnormalities, osteopenia and cardiovascular risk in patients treated for human immunodeficiency virus infection.
    Cirelli A, Cirelli G, Balsamo G, Masciangelo R, Stasolla A, Marini M.
    Ann Ital Med Int; 2003 May 30; 18(4):238-45. PubMed ID: 14971712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.